June 27th 2025
From Nobel laureates to AI-driven research, the Wilmer Eye Institute honors a century of transforming vision science and care.
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Burst CME Plus™ - Unveiling Pharmacological Advances in nAMD & DME: From Durability to Applicability
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Retina Specialists: Join us in Long Beach
July 31, 2025 - August 2, 2025
Register Now!
SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application
View More
Rapid Reviews in Retina™: Emerging Updates from Summer 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
September 6, 2025
Register Now!
Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D
View More
EyeCon 2025
September 26-27, 2025
Register Now!
Optometrists: Earn COPE CE Credits in Portland or Virtually
October 16-17, 2025
Register Now!
Join us at The Ophthalmology Meeting in Orlando this October
October 18, 2025
Register Now!
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)
View More
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)
View More
Community Practice Connections™: Transforming Treatment in nAMD, DME, and DR – Keeping an Eye on Optimal Outcomes
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
Expert Perspectives on Technological Advances in Cataract Surgery
View More
Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy
View More
Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy
View More
(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes
View More
Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs
View More
(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention
View More
Toric trifocal IOL brings expanded range of functional vision to larger patient population
November 1st 2016Trifocal IOLs can provide good uncorrected vision at near, intermediate, and far. Outcomes in a series of 30 patients show that a toric version of a trifocal IOL (AT Lisa tri 939MP, Carl Zeiss Meditec) delivers those benefits for patients with > 1 D of corneal astigmatism.
Read More
New-generation presbyopia-correcting IOL
July 15th 2016The U.S. IDE clinical trial of the investigational extended range of vision IOL (Model ZXR00; Tecnis Symfony Extended Range of Vision IOL, Abbott Medical Optics) found that the implant delivered a full range of uncorrected vision and minimized or eliminated the need for spectacle wear in most patients.
Read More
Technique targets source of rainbow glare symptoms
June 15th 2016Rainbow glare rarely occurs after femto-LASIK surgery and is usually transient. Phototherapeutic keratectomy of the flap undersurface targets the cause of the glare and has been used to immediately resolve symptoms in patients with persistent disabling rainbow glare.
Read More
Keratoconus as refractive surgery: Thinking outside the ‘cone’
June 15th 2016In this first of a two-part series, Arun C. Gulani, MD, MS, explains how approaching keratoconus as a refractive surgery will change the way both ophthalmologists and patients will approach this condition to bring in a new era of not only relieving but also enhancing the lifestyle of this patient population. In Part 2, Dr. Gulani will share strategies and cases of patients with keratoconus with different case scenarios in action.
Read More
Determining best cases for IOL implantation in children
May 1st 2016When the topic of IOL implantation is on the table, the age of the patient does make a difference, according to pediatric expert Courtney Kraus, MD, who spoke at the Wilmer Eye Institute’s 27th annual Current Concepts in Ophthalmology conference.
Read More
How myopia shaped the attitudes of Theodore Roosevelt and Ronald Reagan
January 1st 2016Severe myopia affected the attitudes of both Theodore Roosevelt and Ronald Reagan, but in opposite ways, according to biographer Edmund Morris.“Since both of them became aware of their myopia in their early teens, it was obviously a formative experience for both of them,” Morris told Ophthalmology Times.
Read More
Presbyopia therapy: Comparison of corneal versus lens-based options
December 1st 2015The authors assess the quantitative and qualitative aspects of vision following various lens- and corneal-based therapies for presbyopia. In many cases the KAMRA corneal inlay offers a long-term solution. It can easily be removed if the patient is not satisfied with the outcome.
Read More
Device improves irregular astigmatism in pseudophakic eyes
October 1st 2015A pinhole implant placed in the ciliary sulcus can improve visual acuity and reduce dysphotic symptoms in pseudophakic eyes with irregular corneal astigmatism. Implantation is even easier with the latest version of the investigational device
Read More
Refractive surgery for special needs children: The time is now
October 1st 2015The time for refractive surgery for special needs children seems to be at hand, considering that advancements in laser and IOL technologies have been proven to be efficacious. Correcting a special needs child’s vision can reduce fearfulness and improve their behavioral challenges.
Read More
IOLs in cataract surgery – do the risks outweigh the benefits in infants?
September 1st 2015This article presents recent epidemiological findings outlining the association between cataract surgery, potential visual acuity gains, glaucoma and the risk of undergoing additional general anaesthesia in under 2s. The authors of the original study concluded that use of IOLs in cataract surgery in young children should be critically reassessed, particularly in settings/communities where close, long-term follow-up is challenging.
Read More
The dexamethasone nanowafer: A novel method of drug delivery for dry eye disease
September 1st 2015This review presents a therapeutic nanowafer as an alternative to eye drops for dry eye disease, designed to enhance efficacy and improve patient compliance to treatment. In an experimental animal study, the novel dexamethasone nanowafer drug delivery system was comparable in efficacy to twice-daily dexamethasone eye drop treatment and has the potential to minimise risk of cataract formation and glaucoma.
Read More